Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.21
-0.04-0.76%
At close: -
$5.21
0.000.00%
After Hours: 4:01 PM EDT
Comments
Loading...
Fennec Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:FENC | Benzinga
Fennec Pharmaceuticals Inc has a consensus price target of $14.33 based on the ratings of 6 analysts. The high is $19 issued by Wedbush on September 26, 2022. The low is $11 issued by Capital One on September 7, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 11, 2025, December 17, 2024, and August 22, 2024, respectively. With an average price target of $13 between HC Wainwright & Co., there's an implied 149.52% upside for Fennec Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Cantor Fitzgerald
Cantor Fitzgerald
Wedbush
1calculated from analyst ratings
Analyst Ratings for Fennec Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | Buy Now | 149.52% | HC Wainwright & Co. | Raghuram Selvaraju42% | $13 → $13 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | Buy Now | 149.52% | HC Wainwright & Co. | Raghuram Selvaraju42% | $13 → $13 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2024 | Buy Now | 149.52% | HC Wainwright & Co. | Raghuram Selvaraju42% | $15 → $13 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 187.91% | Craig-Hallum | Chase Knickerbocker43% | $17 → $15 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 226.3% | Craig-Hallum | Chase Knickerbocker43% | $20 → $17 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 187.91% | HC Wainwright & Co. | Raghuram Selvaraju42% | $18 → $15 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | $17 → $18 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | 245.49% | Craig-Hallum | Chase Knickerbocker43% | $17 → $18 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 226.3% | HC Wainwright & Co. | Raghuram Selvaraju42% | $18 → $17 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/06/2023 | Buy Now | 207.1% | Cantor Fitzgerald | Charles Robertson II65% | $12 → $16 | Maintains | Overweight | Get Alert |
| 04/04/2023 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $18 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $18 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | → $18 | Reiterates | → Buy | Get Alert |
| 11/22/2022 | Buy Now | 130.33% | Cantor Fitzgerald | Charles Duncan71% | $9 → $12 | Upgrade | Neutral → Overweight | Get Alert |
| 10/20/2022 | Buy Now | 245.49% | HC Wainwright & Co. | Raghuram Selvaraju42% | $14 → $18 | Maintains | Buy | Get Alert |
| 09/26/2022 | Buy Now | 264.68% | Wedbush | David Nierengarten60% | $11 → $19 | Maintains | Outperform | Get Alert |
| 09/07/2022 | Buy Now | 111.13% | Capital One | Naureen Quibria19% | → $11 | Initiates | → Overweight | Get Alert |
| 08/08/2022 | Buy Now | 168.71% | Craig-Hallum | Chase Knickerbocker43% | → $14 | Assumes | → Buy | Get Alert |
FAQ
What is the target price for Fennec Pharmaceuticals (FENC) stock?
The latest price target for Fennec Pharmaceuticals (NASDAQ:FENC) was reported by HC Wainwright & Co. on March 11, 2025. The analyst firm set a price target for $13.00 expecting FENC to rise to within 12 months (a possible 149.52% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?
The latest analyst rating for Fennec Pharmaceuticals (NASDAQ:FENC) was provided by HC Wainwright & Co., and Fennec Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Fennec Pharmaceuticals (FENC)?
The last upgrade for Fennec Pharmaceuticals Inc happened on November 22, 2022 when Cantor Fitzgerald raised their price target to $12. Cantor Fitzgerald previously had a neutral for Fennec Pharmaceuticals Inc.
When was the last downgrade for Fennec Pharmaceuticals (FENC)?
There is no last downgrade for Fennec Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?
While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a reiterated with a price target of $13.00 to $13.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $5.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.